X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217000
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212472
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-9-2022-1644385243.pdf
https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-xonvea-10-mg-10-mg-gastro-resistant-tablets-mdr-025-10-19
https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/UCM293268.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-cubicin-rf-21572-daptomycin-for-injection-1541062857.pdf
https://www.prnewswire.com/news-releases/duchesnay-usa-announces-launch-of-bonjesta-doxylamine-succinate---pyridoxine-hydrochloride-in-the-united-states-300620521.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208518
http://www.dailymail.co.uk/health/article-4740842/Kim-Kardashian-flouts-FDA-warning-promote-pill.html
https://www.pharmacompass.com/pdf/news/actavis-receives-fda-approval-for-doxylamine-succinate-1472292974.pdf
http://www.fiercepharmamarketing.com/story/want-get-warning-letter-opdp-omit-drug-risks-your-promos/2015-10-05
http://nypost.com/2015/08/31/kim-kardashian-posts-drugs-side-effects-on-instagram-after-fda-warning/
http://www.multivu.com/players/English/7610451-diclegis-corrective-messaging/
http://www.fiercepharmamarketing.com/story/has-kim-kardashian-ruined-pharma-marketing-too-fallout-infamous-instagram-p/2015-08-16
http://www.multivu.com/players/English/7487651-diclegis-available-for-morning-sickness/
Market Place
Share 
